Sign inGet started

Hillan Kenneth J.

Insider CIK 1600359 · SGMO Director · AKAO See Remarks, Director · ZYME Director · RLYP Director · ME Head of Therapeutics · ZYME Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2025-06-122025-06-1650,000— $050,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2025-06-122025-06-1625,000— $099,600SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2024-06-042024-06-0650,000— $050,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2024-06-042024-06-0625,000— $074,600SEC↗
ZYME Zymeworks Inc. A Award deriv2023-12-072023-12-0837,000— $037,000SEC↗
ME 23andMe Holding Co. F Tax w/h2023-06-052023-06-0715,347$2.08 $31.9K221,876SEC↗
ME 23andMe Holding Co. A Award2023-06-052023-06-0744,381— $0237,223SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2023-06-012023-06-0527,750— $027,750SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2023-06-012023-06-0513,900— $049,600SEC↗
ME 23andMe Holding Co. F Tax w/h2023-05-202023-05-234,628$1.94 $9.0K192,842SEC↗
ME 23andMe Holding Co. F Tax w/h2023-02-202023-02-225,457$2.87 $15.7K191,705SEC↗
ZYME Zymeworks Inc. A Award deriv2022-12-212022-12-2325,000— $025,000SEC↗
ME 23andMe Holding Co. F Tax w/h2022-11-202022-11-224,628$2.99 $13.8K197,162SEC↗
ME 23andMe Holding Co. S Sale2022-08-242022-08-258,753$3.64 $31.9K196,083SEC↗
ME 23andMe Holding Co. F Tax w/h2022-08-202022-08-224,628$3.33 $15.4K204,836SEC↗
ME 23andMe Holding Co. F Tax w/h2022-06-012022-06-024,627$2.82 $13.0K209,464SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2022-02-252022-03-0125,000— $025,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2022-02-252022-03-0112,500— $035,700SEC↗
ME 23andMe Holding Co. A Award deriv2022-02-092022-02-11471,413— $0471,413SEC↗
ME 23andMe Holding Co. A Award2022-02-092022-02-11214,091— $0214,091SEC↗
ZYME Zymeworks Inc. A Award deriv2021-05-062021-05-079,000— $09,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2021-02-252021-03-0116,400— $016,400SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2021-02-252021-03-018,200— $023,200SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2020-09-092020-09-1130,000— $030,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2020-09-092020-09-1115,000— $015,000SEC↗
ZYME Zymeworks Inc. A Award deriv2020-05-082020-05-129,000— $09,000SEC↗
ZYME Zymeworks Inc. A Award deriv2019-05-062019-05-0810,000— $010,000SEC↗
AKAO Achaogen Inc M Exercise deriv2018-06-282018-06-29132,727— $00SEC↗
AKAO Achaogen Inc M Exercise deriv2018-06-282018-06-2945,208— $032,292SEC↗
AKAO Achaogen Inc M Exercise2018-06-282018-06-2945,208$3.65 $165.0K293,336SEC↗
AKAO Achaogen Inc M Exercise2018-06-282018-06-29132,727$6.93 $919.8K248,128SEC↗
AKAO Achaogen Inc A Award deriv2018-06-262018-06-2810,000— $010,000SEC↗
AKAO Achaogen Inc S Sale2018-06-262018-06-28744$9.59 $7.1K115,401SEC↗
AKAO Achaogen Inc A Award2018-06-262018-06-282,150— $0116,145SEC↗
AKAO Achaogen Inc S Sale2018-03-132018-03-152,735$11.74 $32.1K95,151SEC↗
AKAO Achaogen Inc S Sale2018-02-212018-02-234,606$10.67 $49.1K97,886SEC↗
AKAO Achaogen Inc A Award deriv2018-02-082018-05-1580,000— $080,000SEC↗
AKAO Achaogen Inc A Award2018-02-082018-05-1517,100— $0112,251SEC↗
AKAO Achaogen Inc S Sale2017-03-142017-03-163,079$26.58 $81.8K98,422SEC↗
AKAO Achaogen Inc A Award deriv2017-02-222017-02-24160,000— $0160,000SEC↗
AKAO Achaogen Inc A Award deriv2017-02-222017-02-2440,000— $040,000SEC↗
AKAO Achaogen Inc A Award2017-02-222017-02-2440,000— $0101,501SEC↗
AKAO Achaogen Inc S Sale2017-02-212017-02-231,696$22.76 $38.6K61,501SEC↗
AKAO Achaogen Inc S Sale2017-01-262017-01-301,431$16.78 $24.0K63,197SEC↗
RLYP Relypsa Inc D To issuer deriv2016-09-012016-09-0212,000— $00SEC↗
RLYP Relypsa Inc D To issuer deriv2016-09-012016-09-024,500— $00SEC↗
RLYP Relypsa Inc D To issuer deriv2016-09-012016-09-024,500— $00SEC↗
RLYP Relypsa Inc D To issuer2016-09-012016-09-022,250$32.00 $72.0K0SEC↗
RLYP Relypsa Inc U Tender2016-09-012016-09-021,237$32.00 $39.6K2,250SEC↗
RLYP Relypsa Inc A Award deriv2016-06-212016-06-234,500— $04,500SEC↗
RLYP Relypsa Inc A Award2016-06-212016-06-232,250— $03,487SEC↗
RLYP Relypsa Inc S Sale2016-06-072016-06-081,013$19.31 $19.6K1,237SEC↗
AKAO Achaogen Inc S Sale2016-03-172016-03-213,572$3.22 $11.5K61,628SEC↗
AKAO Achaogen Inc A Award deriv2016-02-262016-03-0138,750— $038,750SEC↗
AKAO Achaogen Inc A Award deriv2016-02-262016-03-0138,750— $038,750SEC↗
AKAO Achaogen Inc A Award deriv2016-02-262016-03-0177,500— $077,500SEC↗
AKAO Achaogen Inc A Award2016-02-262016-03-0133,000— $065,200SEC↗
RLYP Relypsa Inc A Award deriv2015-06-042015-06-084,500— $04,500SEC↗
RLYP Relypsa Inc A Award2015-06-042015-06-082,250— $02,250SEC↗
AKAO Achaogen Inc A Award deriv2015-03-112015-03-13111,700— $0111,700SEC↗
AKAO Achaogen Inc A Award2015-03-112015-03-1332,200— $032,200SEC↗
RLYP Relypsa Inc A Award deriv2014-06-192014-06-2312,000— $012,000SEC↗